» Articles » PMID: 19131428

Increased Gamma-tubulin Expression and P16INK4A Promoter Methylation Occur Together in Preinvasive Lesions and Carcinomas of the Breast

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2009 Jan 10
PMID 19131428
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Loss of p16(INK4A) due to promoter hypermethylation is correlated with the ability to acquire centrosomal abnormalities in variant human mammary epithelial cells. gamma-Tubulin is a highly conserved component of centrosome in most animal cells and gamma-tubulin protein overexpression could lead to centrosome aberration.

Materials And Methods: A large series of breast premalignant lesions and carcinoma was analyzed. Real-time quantitative PCR and immunohistochemistry were carried out to measure gamma-tubulin copy numbers and protein expression. MethyLight and immunohistochemistry were carried out to determine p16(INK4A) methylation and protein expression.

Results: gamma-Tubulin protein expression was concordant with gene amplification; both of them were found to increase with atypical ductal hyperplasia-carcinoma sequence. The median value and positive rate of p16(INK4a) methylation increased while protein expression displayed a decreasing trend. P16(INK4a) methylation showed a firm association with gamma-tubulin gene amplification.

Conclusion: gamma-Tubulin gene amplification and the concomitant protein overexpression present not only in invasive carcinoma but also in a significant fraction of atypical hyperplasia and in situ carcinomas. P16(INK4a) methylation and gamma-tubulin gene amplification had a synergistic effect on tumor progression. The synergism might arise as a result of the combined influence that p16(INK4a) and gamma-tubulin have on the G1-S cell cycle checkpoints and centrosome.

Citing Articles

Epigenetic alterations impede epithelial-mesenchymal transition by modulating centrosome amplification and Myc/RAS axis in triple negative breast cancer cells.

Das L Sci Rep. 2023; 13(1):2458.

PMID: 36774386 PMC: 9922331. DOI: 10.1038/s41598-023-29712-8.


Dysregulation of Microtubule Nucleating Proteins in Cancer Cells.

Draber P, Draberova E Cancers (Basel). 2021; 13(22).

PMID: 34830792 PMC: 8616210. DOI: 10.3390/cancers13225638.


Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?.

Fanale D, Bronte G, Passiglia F, Calo V, Castiglia M, Di Piazza F Anal Cell Pathol (Amst). 2015; 2015:690916.

PMID: 26484003 PMC: 4592889. DOI: 10.1155/2015/690916.


Kinesin-14 and kinesin-5 antagonistically regulate microtubule nucleation by γ-TuRC in yeast and human cells.

Olmsted Z, Colliver A, Riehlman T, Paluh J Nat Commun. 2014; 5:5339.

PMID: 25348260 PMC: 4220466. DOI: 10.1038/ncomms6339.


Armc8 expression was elevated during atypia-to-carcinoma progression and associated with cancer development of breast carcinoma.

Fan C, Zhao Y, Mao X, Miao Y, Lin X, Jiang G Tumour Biol. 2014; 35(11):11337-43.

PMID: 25119601 DOI: 10.1007/s13277-014-2473-0.